Page last updated: 2024-08-16

rofecoxib and Uterine Cervical Neoplasms

rofecoxib has been researched along with Uterine Cervical Neoplasms in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Grabosch, SM; Helm, CW; Shariff, OM	1
Grabosch, SM; Helm, CW; Shariff, OM; Wulff, JL	1

Reviews

2 review(s) available for rofecoxib and Uterine Cervical Neoplasms

Article	Year
Non-steroidal anti-inflammatory agents to induce regression and prevent the progression of cervical intraepithelial neoplasia. The Cochrane database of systematic reviews, 2018, 02-12, Volume: 2 Topics: Administration, Oral; Adult; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase 2 Inhibitors; Disease Progression; Female; Humans; Induction Chemotherapy; Lactones; Placebos; Randomized Controlled Trials as Topic; Sulfonamides; Sulfones; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms	2018
Non-steroidal anti-inflammatory agents to induce regression and prevent the progression of cervical intraepithelial neoplasia. The Cochrane database of systematic reviews, 2014, Apr-09, Issue:4 Topics: Administration, Oral; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase 2 Inhibitors; Disease Progression; Female; Humans; Induction Chemotherapy; Lactones; Pyrazoles; Randomized Controlled Trials as Topic; Sulfonamides; Sulfones; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms	2014

Article

Year

Non-steroidal anti-inflammatory agents to induce regression and prevent the progression of cervical intraepithelial neoplasia.

The Cochrane database of systematic reviews, 2018, 02-12, Volume: 2

Topics: Administration, Oral; Adult; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase 2 Inhibitors; Disease Progression; Female; Humans; Induction Chemotherapy; Lactones; Placebos; Randomized Controlled Trials as Topic; Sulfonamides; Sulfones; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms

2018

Non-steroidal anti-inflammatory agents to induce regression and prevent the progression of cervical intraepithelial neoplasia.

The Cochrane database of systematic reviews, 2014, Apr-09, Issue:4

Topics: Administration, Oral; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase 2 Inhibitors; Disease Progression; Female; Humans; Induction Chemotherapy; Lactones; Pyrazoles; Randomized Controlled Trials as Topic; Sulfonamides; Sulfones; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms

2014